Australia markets closed

Isracann Biosciences Inc. (A491.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.08500.0000 (0.00%)
At close: 04:55PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/05/2022
31/05/2021
31/05/2020
Total revenue
0
0
0
0
Operating expenses
Selling general and administrative
2,295
2,506
4,893
11,729
Total operating expenses
2,336
2,547
4,934
11,775
Operating income or loss
-2,336
-2,547
-4,934
-11,775
Interest expense
0
14.149
139.425
0
Total other income/expenses net
-2,275
-2,225
-20,094
-12,353
Income before tax
-4,540
-4,693
-25,092
-23,988
Income tax expense
-
0
31.034
-68.5
Income from continuing operations
-4,540
-4,693
-25,123
-23,919
Net income
-4,540
-4,693
-25,155
-24,202
Net income available to common shareholders
-4,540
-4,693
-25,155
-24,202
Basic EPS
-
-
-
-0.26
Diluted EPS
-
-
-
-0.26
Basic average shares
-
-
-
92,758
Diluted average shares
-
-
-
92,758